Thymulin

Intervention

1 paper4 findings

PubChem

  • 1 lab in 1 country
  • Funder: National Cancer Institute
  • Animals1

Outcomes

4

Tumor sensitivity to anti-PD-L1 therapy

upin animals1

1 study
  1. Thymulin increases tumor sensitivity to anti-PD-L1 therapy.

    “Furthermore, thymulin enhances antitumor T-cell immunity, improves tumor control and survival, and sensitizes tumors to anti-PD-L1 therapy in an age-dependent manner.”

    Animalsage-dependent effecttumor

    Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

    Nature communications21 Jul 2026

Survival

upin animals1

1 study
  1. Thymulin increases survival.

    “Furthermore, thymulin enhances antitumor T-cell immunity, improves tumor control and survival”

    Animalscancer

    Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

    Nature communications21 Jul 2026

Antitumor T-cell immunity

upin animals1

1 study
  1. Thymulin increases antitumor T-cell immunity.

    “Furthermore, thymulin enhances antitumor T-cell immunity”

    Animals

    Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

    Nature communications21 Jul 2026

Pro-inflammatory cytokine production

downin animals1

1 study
  1. Thymulin decreases pro-inflammatory cytokine production.

    “as a mediator that suppresses pro-inflammatory cytokine production by inhibiting NF-κB signaling.”

    Animalsthrough inhibition of NF-κB signalingmyeloid cell

    Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

    Nature communications21 Jul 2026

More on Pro-inflammatory cytokine production

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months